Levonorgestrel-releasing (20 μg/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives

British Journal of Obstetrics and Gynaecology

Volumn 107, Issue 10, 2000, Pages 1218-1225

  French, R S ^a   Cowan, F M ^a   Mansour, D ^b   Higgins, J P T ^c   Robinson, A ^d   Procter, T ^e   Morris, S ^f   Guillebaud, J ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CAMDEN AND ISLINGTON NHS FOUNDATION TRUST   (United Kingdom)

^e Islington Community Health Care Council   (United Kingdom)

^f CITY UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

AMENORRHEA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; HORMONAL CONTRACEPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; META ANALYSIS; PARENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VAGINA BLEEDING;

CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; COUNSELING; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENSTRUATION DISTURBANCES; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 0033799594     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb11610.x     Document Type: Article

References (35)

1. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia
2. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy
3. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathoc menorrhagia
4. Implantable contraceptives, subdermal implants and hormonally impregnated intrauterine systems, versus other forms of reversible contraceptives: Two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness
5. Factors in human fertility and their statistical evaluation
6. Methodological pitfalls in the analysis of contraceptive failure
7. An approach to the analyses of menstrual patterns in the critical evaluation of contraceptives
8. Meta-analytic tools for medical decision making: A practical guide
9. Meta-analysis in clinical trials
10. A 12-month comparative clinical investigation of a levonorgestrel-releasing intracervical device situated in the uterine cavity or cervical canal
11. Levonorgestrel-releasing and copper-releasing (Nova T) intrauterine devices during five years of use: A randomized comparative trial
12. Hormonal intrauterine devices
13. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T
14. Protective effect of intrauterine release of levonorgestrel on pelvic infection: Three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices
15. Ensimmaisen vuoden kokemukset levonorgestreeliehkaisimesta. [One year experience of levonorgestrel-releasing intrauterine device]
16. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study
17. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380 Ag intrauterine contraceptive devices: A multicenter study. International Committee for Contraception Research (ICCR)
18. Prolonged intrauterine contraception: A seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag intrauterine devices
19. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380 Ag intrauterine devices: A five-year randomized study
20. Two years of intrauterine contraception with levonorgestrel and with copper: A randomized comparison of the TCu 380 Ag and levonorgestrel 20 mcg/day devices
21. Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device
22. Intrauterine contraception with copper and with levonorgestrel: A randomized study of the TCu 380 Ag and levonorgestrel 20 mcg/day devices
23. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380 Ag intrauterine contraceptive devices
24. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: A randomized comparative performance study
25. Five years' experience with levonorgestrel-releasing intrauterine devices
26. Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device
27. Intrauterine contraception with levonorgestrel: A comparative randomised clinical performance study
28. Three years' experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: A randomized comparative study
29. Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing intrauterine device, Norplant-2 implants in China
30. Comparative study of norplant-2 and levonorgestrel-releasing intrauterine devices
31. Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (levonorgestrel), CuT 380 Ag, CuT 220 C, CuT 200 B). A 36-month study. Indian Council of Medical Research Task Force on intrauterine device